Brustimplantatassoziiertes Lymphom und Laktation – eine seltene Kombination

Katrin Julia Messingschlager; Massud Mamarvar

doi:10.1055/a-0800-6025

Geburtshilfe und Frauenheilkunde, Table of Contents

Geburtshilfe Frauenheilkd 2019; 79(03): 250-253
DOI: 10.1055/a-0800-6025

GebFra Magazin

Der interessante Fall

Georg Thieme Verlag KG Stuttgart · New York

Brustimplantatassoziiertes Lymphom und Laktation – eine seltene Kombination

Katrin Julia Messingschlager

,

Massud Mamarvar

Abstract

Das Brustimplantat-assoziierte anaplastische großzellige Lymphom (BIA-ALCL) ist eine neue, sehr seltene Tumorentität. Seit einigen Jahren gibt es vermehrt Hinweise, dass Brustimplantate mit dem Auftreten eines anaplastischen großzelligen Lymphoms in Zusammenhang stehen können. Bisher sind 7 Fälle in Deutschland bekannt und beschrieben worden. Wir stellen den 8. Fall eines BIA-ALCL mit der Besonderheit des Auftretens während der Laktation vor.

Full Text

References

Literatur
1 Kricheldorff J, Fallenberg EM, Sobach C. et al. Brustimplantat-assoziiertes Lymphom. Dtsch Arztebl Int 2018; 115: 628-635
2 FDA. Medical device reports of breast implant-associated anaplastic large cell lymphoma. Online: https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/BreastImplants/ucm481899.htm Stand: 08.04.2018
3 Swerdlow SH, Campo E, Pileri SA. et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016; 127: 2375-2390
4 Clemens MW, Horwitz SM. NCCN consensus guidelines guidelines for the diagnosis and management of breast implant-associated anaplastical large cell lymphoma. Aesthet Surg J 2017; 37: 285-289
5 Clemens MW, Medeiros LJ, Butler CE. et al. Complete surgical excision is esssential for management of patients with breast implant-associated anaplastic large-cell lymphoms. J Clin Oncol 2016; 34: 160-168
6 Loch-Wilkinson A, Beath KJ, Knight RJW. et al. Breast implant-associated anaplastic large-cell lymphoma in Australia and New Zealand: high-surface-area textured implants are associated with increased risk. Plast Reconstr Surg 2017; 140: 645-654
7 George EV, Pharm J, Houston C. et al. Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis. Int J Clin Exp Pathol 2013; 6: 1631-1642
8 Bizjak M, Selmi C, Praprotnik S. et al. Silicone implants and lymphoma: The role of inflammation. J Autoimmun 2015; 65: 64-73
9 Orciani M, Sorgentoni G, Torresetti M. et al. MSCs and inflammation: new insights into potential association between ALCL and breast implants. Breast Cancer Res Treat 2016; 156: 65-72
10 Hu H, Johani K, Almatroudi A. et al. Bacterial biofilm infection detected in breast implant-associated anaplastic large-cell lymphoma. Plast Reconstr Surg 2016; 137: 1659-1669
11 Adams jr. WP. Discussion: Bacterial biofilm infection detected in breast implant-associated anaplastic large-cell Lymphoma. Plast Reconstr Surg 2016; 137: 1670-1672
12 Kim B, Predmore ZS, Mattke S. et al. Breast-implant-associated anaplastic largecell lymphoma: updated results from a structured expert consultation process. Plast Reconstr Surg Glob Open 2015; 3: e296
13 NCCN. Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Hodgkinʼs Lymphomas. Online: https://www.nccn.org/professionals/physician_gls/f_guidelines.asp#nhl Stand: 15.12.2017
14 Clemens MW, Miranda RN. Coming of age: breast implant-associated anaplastic large cell lymphoma after 18 years of investigation. Clin Plast Surg 2015; 42: 605-613
15 Bautista-Quach MA, Nademanee A, Weisenburger DD. et al. Implant-associated primary anaplastic large-cell lymphoma with simultanous involvement of bilateral breast capsules. Clin Breast Cancer 2013; 13: 492-495